COVID-19

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

Shots: Nuvaxovid (NVX-CoV2373) received expanded authorization from Health Canada...

Pfizer and BioNTech Reports P-II/III Trial Results of Omicron BA.4/BA.5-Adapted Bivalent Booster for COVID-19

Pfizer and BioNTech Reports P-II/III Trial Results of Omicron BA.4/BA.5-Adapted Bivalent Booster for COVID-19

Shots: The P-II/III trial to evaluate Omicron BA.4/BA.5-Adapted Bivalent Booster (...

Rigel Reports P-III (FOCUS) Trial Results of Fostamatinib for COVID-19 in High Risk Hospitalized Patients

Rigel Reports P-III (FOCUS) Trial Results of Fostamatinib for COVID-19 in High Risk Hospitalized Patients

Shots: The P-III (FOCUS) trial evaluates fostamatinib (BID) + SoC vs PBO + SoC in...

Arcturus Collaborated with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines

Arcturus Collaborated with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines

Shots: Arcturus will receive $200M up front, ~$1.3B in development milestones &...

Image